Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis
- 15 October 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 52 (2), 165-171
- https://doi.org/10.1016/0049-3848(88)90095-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Plasma antithrombin activity of MD 805 determined by chromogenic substrate during hemodialysis.Blood & Vessel, 1987
- Heparin‐induced thrombocytopenia: further studies of the effects of heparin‐dependent antibodies on plateletsBritish Journal of Haematology, 1986
- Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuitThrombosis Research, 1986
- A diagnostic test for heparin-induced thrombocytopeniaBlood, 1986
- Heparin-associated thrombocytopenia: antibody binding specificity to platelet antigensBlood, 1985
- Effects of low-molecular-weight heparin on platelets as compared with commercial heparinZeitschrift für Die Gesamte Experimentelle Medizin, 1984
- ASPIRIN PREVENTS HEPARIN‐INDUCED PLATELET AGGREGATION IN VIVOBritish Journal of Haematology, 1983
- Heparin‐induced Thrombocytopenia: Effect of Heparin Platelet Antibody on PlateletsBritish Journal of Haematology, 1981
- Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1980